首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Candidate Sulfonated and Sulfated Topical Microbicides: Comparison of Anti-Human Immunodeficiency Virus Activities and Mechanisms of Action
【2h】

Candidate Sulfonated and Sulfated Topical Microbicides: Comparison of Anti-Human Immunodeficiency Virus Activities and Mechanisms of Action

机译:候选的磺化和硫酸化局部杀微生物剂:抗人类免疫缺陷病毒活性和作用机制的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poly(styrene 4-sulfonate), cellulose sulfate, polymethylenehydroquinone, and PRO 2000 are sulfated or sulfonated polymers (SPs) under development as topical microbicides. They are presumed to work through similar mechanisms of action, although to date there has been no extensive comparison of their anti-human immunodeficiency virus activities. To determine whether any of these candidate microbicides offers a potential advantage, their in vitro activities, mechanisms of action, stabilities in biological secretions, and toxicities were compared. All four compounds were found to be active against X4, R5, and dualtropic primary isolates and against X4 and R5 laboratory-adapted strains in CD4+ T cells, macrophages, and single-coreceptor cell lines. Our single-cycle experiments using pseudotyped virus suggest that all four SPs function at the binding and entry stages of the viral life cycle but differ in degree of postentry effect. Surface plasmon resonance analyses demonstrate that SPs bind to X4 and R5 monomeric glycoprotein 120 with similar high binding affinities. When mixed with cervicovaginal lavage fluid, SPs maintain inhibitory activity at concentrations achievable in formulations.
机译:聚(苯乙烯4-磺酸盐),硫酸纤维素,聚亚甲基对苯二酚和PRO 2000是作为局部杀菌剂开发的硫酸化或磺化聚合物(SP)。据推测,它们通过类似的作用机制起作用,尽管迄今为止,它们的抗人类免疫缺陷病毒活性尚未得到广泛的比较。为了确定这些候选杀微生物剂是否具有潜在优势,将它们的体外活性,作用机理,生物分泌的稳定性和毒性进行了比较。发现这四种化合物对CD4 + T细胞,巨噬细胞和单共受体细胞系中的X4,R5和双嗜性原代分离物以及对X4和R5实验室适应的菌株均具有活性。我们使用假型病毒的单周期实验表明,所有四个SP在病毒生命周期的结合和进入阶段均起作用,但进入后作用的程度不同。表面等离子体共振分析表明,SP以相似的高结合亲和力结合X4和R5单体糖蛋白120。当与宫颈阴道灌洗液混合时,SP在制剂中可以达到的浓度下保持抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号